Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Exploring genome-wide - dietary heme iron intake interactions and the risk of type 2 diabetes.

Frontiers in genetics

Pasquale LR, Loomis SJ, Aschard H, Kang JH, Cornelis MC, Qi L, Kraft P, Hu FB.
PMID: 23386860
Front Genet. 2013 Jan 30;4:7. doi: 10.3389/fgene.2013.00007. eCollection 2013.

AIMS/HYPOTHESIS: Genome-wide association studies have identified over 50 new genetic loci for type 2 diabetes (T2D). Several studies conclude that higher dietary heme iron intake increases the risk of T2D. Therefore we assessed whether the relation between genetic loci...

Cite
Pasquale LR, Loomis SJ, Aschard H, et al. Exploring genome-wide - dietary heme iron intake interactions and the risk of type 2 diabetes. Front Genet. 2013;4:7doi: 10.3389/fgene.2013.00007.
Pasquale, L. R., Loomis, S. J., Aschard, H., Kang, J. H., Cornelis, M. C., Qi, L., Kraft, P., & Hu, F. B. (2013). Exploring genome-wide - dietary heme iron intake interactions and the risk of type 2 diabetes. Frontiers in genetics, 47. https://doi.org/10.3389/fgene.2013.00007
Pasquale, Louis R, et al. "Exploring genome-wide - dietary heme iron intake interactions and the risk of type 2 diabetes." Frontiers in genetics vol. 4 (2013): 7. doi: https://doi.org/10.3389/fgene.2013.00007
Pasquale LR, Loomis SJ, Aschard H, Kang JH, Cornelis MC, Qi L, Kraft P, Hu FB. Exploring genome-wide - dietary heme iron intake interactions and the risk of type 2 diabetes. Front Genet. 2013 Jan 30;4:7. doi: 10.3389/fgene.2013.00007. eCollection 2013. PMID: 23386860; PMCID: PMC3558725.
Copy Download .nbib Format: NLM
Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk.

International journal of molecular epidemiology and genetics

Pinheiro SP, Gates MA, De Vivo I, Rosner BA, Tworoger SS, Titus-Ernstoff L, Hankinson SE, Cramer DW.
PMID: 21532843
Int J Mol Epidemiol Genet. 2010 Sep 03;1(4):320-31.

Inflammation and non-steroidal anti-inflammatory agents (NSAIDs) may play important role in ovarian cancer. However, epidemiologic data are inconsistent, possibly reflecting inter-individual genetic differences affecting the metabolism of NSAIDs. We examined whether common polymorphisms affecting the metabolism of NSAIDs modify...

Cite
Pinheiro SP, Gates MA, De Vivo I, et al. Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. Int J Mol Epidemiol Genet. 2010;1(4):320-31
Pinheiro, S. P., Gates, M. A., De Vivo, I., Rosner, B. A., Tworoger, S. S., Titus-Ernstoff, L., Hankinson, S. E., & Cramer, D. W. (2010). Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. International journal of molecular epidemiology and genetics, 1(4), 320-31.
Pinheiro, Simone P, et al. "Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk." International journal of molecular epidemiology and genetics vol. 1,4 (2010): 320-31.
Pinheiro SP, Gates MA, De Vivo I, Rosner BA, Tworoger SS, Titus-Ernstoff L, Hankinson SE, Cramer DW. Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk. Int J Mol Epidemiol Genet. 2010 Sep 03;1(4):320-31. PMID: 21532843; PMCID: PMC3076777.
Copy Download .nbib Format: NLM
Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome.

BMC clinical pathology

Shurubor YI, Matson WR, Willett WC, Hankinson SE, Kristal BS.
PMID: 17997839
BMC Clin Pathol. 2007 Nov 12;7:9. doi: 10.1186/1472-6890-7-9.

BACKGROUND: Biomarker-based assessments of biological samples are widespread in clinical, pre-clinical, and epidemiological investigations. We previously developed serum metabolomic profiles assessed by HPLC-separations coupled with coulometric array detection that can accurately identify ad libitum fed and caloric-restricted rats. These...

Cite
Shurubor YI, Matson WR, Willett WC, et al. Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC Clin Pathol. 2007;7:9doi: 10.1186/1472-6890-7-9.
Shurubor, Y. I., Matson, W. R., Willett, W. C., Hankinson, S. E., & Kristal, B. S. (2007). Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC clinical pathology, 79. https://doi.org/10.1186/1472-6890-7-9
Shurubor, Yevgeniya I, et al. "Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome." BMC clinical pathology vol. 7 (2007): 9. doi: https://doi.org/10.1186/1472-6890-7-9
Shurubor YI, Matson WR, Willett WC, Hankinson SE, Kristal BS. Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC Clin Pathol. 2007 Nov 12;7:9. doi: 10.1186/1472-6890-7-9. PMID: 17997839; PMCID: PMC2203971.
Copy Download .nbib Format: NLM
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.

Journal of translational genetics and genomics

Moore A, Machiela MJ, Machado M, Wang SS, Kane E, Slager SL, Zhou W, Carrington M, Lan Q, Milne RL, Birmann BM, Adami HO, Albanes D, Arslan AA, Becker N, Benavente Y, Bisanzi S, Boffetta P, Bracci PM, Brennan P, Brooks-Wilson AR, Canzian F, Caporaso N, Clavel J, Cocco P, Conde L, Cox DG, Cozen W, Curtin K, De Vivo I, de Sanjose S, Foretova L, Gapstur SM, Ghesquières H, Giles GG, Glenn M, Glimelius B, Gao C, Habermann TM, Hjalgrim H, Jackson RD, Liebow M, Link BK, Maynadie M, McKay J, Melbye M, Miligi L, Molina TJ, Monnereau A, Nieters A, North KE, Offit K, Patel AV, Piro S, Ravichandran V, Riboli E, Salles G, Severson RK, Skibola CF, Smedby KE, Southey MC, Spinelli JJ, Staines A, Stewart C, Teras LR, Tinker LF, Travis RC, Vajdic CM, Vermeulen RCH, Vijai J, Weiderpass E, Weinstein S, Doo NW, Zhang Y, Zheng T, Chanock SJ, Rothman N, Cerhan JR, Dean M, Camp NJ, Yeager M, Berndt SI.
PMID: 34622145
J Transl Genet Genom. 2021;5:200-217. doi: 10.20517/jtgg.2021.08. Epub 2021 Jun 17.

AIM: Recessive genetic variation is thought to play a role in non-Hodgkin lymphoma (NHL) etiology. Runs of homozygosity (ROH), defined based on long, continuous segments of homozygous SNPs, can be used to estimate both measured and unmeasured recessive genetic...

Cite
Moore A, Machiela MJ, Machado M, et al. Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. J Transl Genet Genom. 2021;5:200-217doi: 10.20517/jtgg.2021.08.
Moore, A., Machiela, M. J., Machado, M., Wang, S. S., Kane, E., Slager, S. L., Zhou, W., Carrington, M., Lan, Q., Milne, R. L., Birmann, B. M., Adami, H. O., Albanes, D., Arslan, A. A., Becker, N., Benavente, Y., Bisanzi, S., Boffetta, P., Bracci, P. M., Brennan, P., Brooks-Wilson, A. R., Canzian, F., Caporaso, N., Clavel, J., Cocco, P., Conde, L., Cox, D. G., Cozen, W., Curtin, K., De Vivo, I., de Sanjose, S., Foretova, L., Gapstur, S. M., Ghesquières, H., Giles, G. G., Glenn, M., Glimelius, B., Gao, C., Habermann, T. M., Hjalgrim, H., Jackson, R. D., Liebow, M., Link, B. K., Maynadie, M., McKay, J., Melbye, M., Miligi, L., Molina, T. J., Monnereau, A., Nieters, A., North, K. E., Offit, K., Patel, A. V., Piro, S., Ravichandran, V., Riboli, E., Salles, G., Severson, R. K., Skibola, C. F., Smedby, K. E., Southey, M. C., Spinelli, J. J., Staines, A., Stewart, C., Teras, L. R., Tinker, L. F., Travis, R. C., Vajdic, C. M., Vermeulen, R. C. H., Vijai, J., Weiderpass, E., Weinstein, S., Doo, N. W., Zhang, Y., Zheng, T., Chanock, S. J., Rothman, N., Cerhan, J. R., Dean, M., Camp, N. J., Yeager, M., & Berndt, S. I. (2021). Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. Journal of translational genetics and genomics, 5200-217. https://doi.org/10.20517/jtgg.2021.08
Moore, Amy, et al. "Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes." Journal of translational genetics and genomics vol. 5 (2021): 200-217. doi: https://doi.org/10.20517/jtgg.2021.08
Moore A, Machiela MJ, Machado M, Wang SS, Kane E, Slager SL, Zhou W, Carrington M, Lan Q, Milne RL, Birmann BM, Adami HO, Albanes D, Arslan AA, Becker N, Benavente Y, Bisanzi S, Boffetta P, Bracci PM, Brennan P, Brooks-Wilson AR, Canzian F, Caporaso N, Clavel J, Cocco P, Conde L, Cox DG, Cozen W, Curtin K, De Vivo I, de Sanjose S, Foretova L, Gapstur SM, Ghesquières H, Giles GG, Glenn M, Glimelius B, Gao C, Habermann TM, Hjalgrim H, Jackson RD, Liebow M, Link BK, Maynadie M, McKay J, Melbye M, Miligi L, Molina TJ, Monnereau A, Nieters A, North KE, Offit K, Patel AV, Piro S, Ravichandran V, Riboli E, Salles G, Severson RK, Skibola CF, Smedby KE, Southey MC, Spinelli JJ, Staines A, Stewart C, Teras LR, Tinker LF, Travis RC, Vajdic CM, Vermeulen RCH, Vijai J, Weiderpass E, Weinstein S, Doo NW, Zhang Y, Zheng T, Chanock SJ, Rothman N, Cerhan JR, Dean M, Camp NJ, Yeager M, Berndt SI. Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. J Transl Genet Genom. 2021;5:200-217. doi: 10.20517/jtgg.2021.08. Epub 2021 Jun 17. PMID: 34622145; PMCID: PMC8494431.
Copy Download .nbib Format: NLM
Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.

medRxiv : the preprint server for health sciences

Verdiesen RM, van der Schouw YT, van Gils CH, Verschuren WM, Broekmans FJ, Borges MC, Soares AL, Lawlor DA, Eliassen AH, Kraft P, Sandler DP, Harlow SD, Smith JA, Santoro N, Schoemaker MJ, Swerdlow AJ, Murray A, Ruth KS, Onland-Moret NC.
PMID: 33173903
medRxiv. 2020 Nov 03; doi: 10.1101/2020.10.29.20221390.

Anti-Müllerian hormone (AMH) is expressed by antral stage ovarian follicles in women. Consequently, circulating AMH levels are detectable until menopause. Variation in age-specific AMH levels has been associated with breast cancer and polycystic ovary syndrome (PCOS), amongst other diseases....

Cite
Verdiesen RM, van der Schouw YT, van Gils CH, et al. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women. medRxiv. 2020;doi: 10.1101/2020.10.29.20221390.
Verdiesen, R. M., van der Schouw, Y. T., van Gils, C. H., Verschuren, W. M., Broekmans, F. J., Borges, M. C., Soares, A. L., Lawlor, D. A., Eliassen, A. H., Kraft, P., Sandler, D. P., Harlow, S. D., Smith, J. A., Santoro, N., Schoemaker, M. J., Swerdlow, A. J., Murray, A., Ruth, K. S., & Onland-Moret, N. C. (2020). Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.10.29.20221390
Verdiesen, Renée Mg, et al. "Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.10.29.20221390
Verdiesen RM, van der Schouw YT, van Gils CH, Verschuren WM, Broekmans FJ, Borges MC, Soares AL, Lawlor DA, Eliassen AH, Kraft P, Sandler DP, Harlow SD, Smith JA, Santoro N, Schoemaker MJ, Swerdlow AJ, Murray A, Ruth KS, Onland-Moret NC. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women. medRxiv. 2020 Nov 03; doi: 10.1101/2020.10.29.20221390. PMID: 33173903; PMCID: PMC7654897.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries